Cellular Therapies for Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is a subtype of B-cell non-Hodgkin lymphoma (NHL) characterized by the presence of t(11;14) (q13;q32) translocation, resulting in overexpression of cyclin D11, 2. MCL commonly presents in the seventh decade of life (median age 65 years) with a heterogeneous clinical presentation2. The 2016 World Health Organization updated classification of the lymphoid neoplasms identifies 2 major MCL clinical entities, namely the classical or conventional MCL (cMCL), and the leukemic non-nodal MCL (nnMCL)3.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Farah Yassine, Jose Sandoval-Sus, Ernesto Ayala, Julio Chavez, Mehdi Hamadani, Mohamed A. Kharfan-Dabaja Source Type: research
More News: Biology | Hematology | International Medicine & Public Health | Leukemia | Lymphoma | Non-Hodgkin's Lymphoma | Translocation | Transplants | WHO